DLHAX Holdings Information

DLHAX is a mutual fund with a total of 107 individual holdings. The top holdings are UCB SA stock at 5.45%, Pfizer at 4.27%, Regeneron Pharmaceuticals at 4.12%, Eli Lilly and Company at 4.10%, and Gilead Sciences at 4.03%.

Total Holdings

107

Top 10 Percentage

40.29%

Asset Class

Equity

Fund Category

Health

Assets

750.22M

Forward PE Ratio

14.59

Breakdown by Asset Class

Top 25 Holdings

No.	Symbol	Name	% Weight	Shares
1	EBR: UCB	UCB SA	5.45%	130,137
2	PFE	Pfizer Inc.	4.27%	1,145,000
3	REGN	Regeneron Pharmaceuticals, Inc.	4.12%	47,000
4	LLY	Eli Lilly and Company	4.10%	26,000
5	GILD	Gilead Sciences, Inc.	4.03%	210,000
6	ABBV	AbbVie Inc.	3.88%	125,000
7	UNH	UnitedHealth Group Incorporated	3.80%	70,000
8	MRK	Merck & Co., Inc.	3.64%	215,000
9	ELV	Elevance Health, Inc.	3.53%	63,000
10	LON: AZN	AstraZeneca PLC	3.48%	131,243
11	SWX: ROP	Roche Holding AG	3.31%	55,000
12	TYO: 4519	Chugai Pharmaceutical Co., Ltd.	3.18%	450,000
13	VTRS	Viatris Inc.	2.71%	1,170,018
14	AMGN	Amgen Inc.	2.26%	47,000
15	ILMN	Illumina, Inc.	2.09%	90,000
16	HALO	Halozyme Therapeutics, Inc.	2.09%	220,000
17	BSX	Boston Scientific Corporation	1.72%	250,000
18	VRTX	Vertex Pharmaceuticals Incorporated	1.60%	25,000
19	ORKA	Oruka Therapeutics, Inc.	1.59%	190,000
20	NBIX	Neurocrine Biosciences, Inc.	1.58%	70,000
21	ALKS	Alkermes plc	1.56%	260,000
22	VKTX	Viking Therapeutics, Inc.	1.54%	330,100
23	EPA: SAN	Sanofi	1.50%	120,000
24	ZBH	Zimmer Biomet Holdings, Inc.	1.46%	124,000
25	ROIV	Roivant Sciences Ltd.	1.45%	338,181

Showing 25 of 107 holdings

Subscribe to see the full list

Activate Now

As of May 31, 2026